New Delhi: Reiterating that India will play a big role in Covid-19 vaccine manufacturing, Officer-on-Special Duty (OSD) in the health ministry Rajesh Bhushan informed that 2150 volunteers are undergoing the clinical trial of two indigenous Covid-19 vaccines in the country.
"Two indigenous Covid-19 vaccines are undergoing phase I and II clinical trials. For one vaccine 1150 people have been volunteered and 1000 people have volunteered for the second indigenous vaccine," said Bhusan said at a press conference.
He informed that 24 vaccine candidates across the globe are under clinical evaluation whereas 141 vaccines are in the pre-clinical evaluation stage.
"There is one vaccine candidate each in USA, UK and China which are undergoing phase III clinical trial of Covid-19 vaccine," said Bhusan.
In the global platform, India will play a big role in the distribution of COVID-19 vaccine under WHO's Access to COVID Tool Acceleration (ACT) system.
"We will certainly have priority of Covid-19 vaccine which, of course, need to be administered on a larger scale," said Bhusan.
He informed that health ministry has received as many as 131 life insurance claim for Rs 50 lakh.
"In 20 cases money of the insurance has already been distributed. In 64 cases, the process is on and 47 cases are with the concerned State Government," informed Bhushan.
The maximum contribution has come from states like Maharashtra, Delhi and Telangana.
The government has earlier announced Rs 50 lakh insurance for health care workers who die on the line of duty.
Referring to West Bengal and Bihar, Bhushan said that health ministry is in constant touch with the state government so that Covid-19 could be managed and contained.
Referring to WHO's stand on community transmission of COVID cases, Bhushan ruled out the possibility of such transmission.
"In our case, the infection is traceable and it is a localised one. In 80 per cent cases, it is also possible to trace down the contact of new COVID cases in 72 hours," said Bhusan.
He further informed that out of 739 districts in India, 50 districts carry 80 per cent of the COVID caseload.
Bhushan further said that India's Covid-19 recovery rate is 1.9 times higher than the active cases. The number of active cases at present is 5,28,242 against the total recovery number of 10,20,582.